Gut microbiome in ADHD and its relation to neural reward anticipation

PLoS ONE

Volumn 12, Issue 9, 2017, Pages

  Aarts, Esther ^a   Ederveen, Thomas H A ^b   Naaijen, Jilly ^c   Zwiers, Marcel P ^a   Boekhorst, Jos ^b,d   Timmerman, Harro M ^d   Smeekens, Sanne P ^e   Netea, Mihai G ^e   Buitelaar, Jan K ^c,f   Franke, Barbara ^c   Van Hijum, Sacha A F T ^b,d   Vasquez, Alejandro Arias ^c  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY   (Netherlands)

^d NIZO FOOD RESEARCH   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXADIENYL DEHYDRATASE; HYDROLYASE; PHENYLALANINE; RNA 16S; UNCLASSIFIED DRUG; PREPHENATE DEHYDRATASE;

ADOLESCENT; ADULT; AMINO ACID SYNTHESIS; ANTICIPATION; ARTICLE; ATTENTION DEFICIT DISORDER; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BIFIDOBACTERIUM; BLOOD BRAIN BARRIER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE AMPLIFICATION; GENE FUNCTION; GENE SEQUENCE; GENETIC CODE; HUMAN; INTESTINE FLORA; MALE; NONHUMAN; PILOT STUDY; REWARD; RNA GENE; VENTRAL STRIATUM; BIOLOGICAL MODEL; COHORT ANALYSIS; COMPLICATION; GASTROINTESTINAL DISEASE; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIFIDOBACTERIUM; COHORT STUDIES; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MICROBIOME; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, NEUROLOGICAL; PILOT PROJECTS; PREPHENATE DEHYDRATASE; REWARD; RNA, RIBOSOMAL, 16S; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85029218925     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0183509     Document Type: Article

References (48)

1. Faraone SV, Asherson P, Banaschewski T, Biederman J, Buitelaar JK, Ramos-Quiroga JA, et al. Attention-deficit/hyperactivity disorder. Nature reviews disease primers. 2015:15020. https://doi.org/10.1038/nrdp.2015.20 PMID: 27189265
2. Faraone SV, Glatt SJ. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. The Journal of clinical psychiatry. 2010; 71(6):754–63. https://doi.org/10.4088/JCP.08m04902pur PMID: 20051220.
3. Knutson B, Gibbs SE. Linking nucleus accumbens dopamine and blood oxygenation. Psychopharmacology. 2007; 191(3):813–22. https://doi.org/10.1007/s00213-006-0686-7 PMID: 17279377.
4. Scheres A, Milham MP, Knutson B, Castellanos FX. Ventral striatal hyporesponsiveness during reward anticipation in attention-deficit/hyperactivity disorder. Biological psychiatry. 2007; 61(5):720–4. https://doi.org/10.1016/j.biopsych.2006.04.042 PMID: 16950228.
5. Strohle A, Stoy M, Wrase J, Schwarzer S, Schlagenhauf F, Huss M, et al. Reward anticipation and outcomes in adult males with attention-deficit/hyperactivity disorder. NeuroImage. 2008; 39(3):966–72. https://doi.org/10.1016/j.neuroimage.2007.09.044 PMID: 17996464.
6. Plichta MM, Scheres A. Ventral-striatal responsiveness during reward anticipation in ADHD and its relation to trait impulsivity in the healthy population: a meta-analytic review of the fMRI literature. Neuroscience and biobehavioral reviews. 2014; 38:125–34. https://doi.org/10.1016/j.neubiorev.2013.07.012 PMID: 23928090; PubMed Central PMCID: PMC3989497.
7. Hoogman M, Aarts E, Zwiers M, Slaats-Willemse D, Naber M, Onnink M, et al. Nitric oxide synthase genotype modulation of impulsivity and ventral striatal activity in adult ADHD patients and healthy comparison subjects. The American journal of psychiatry. 2011; 168(10):1099–106. https://doi.org/10.1176/appi.ajp.2011.10101446 PMID: 21724667.
8. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biological psychiatry. 2005; 57(11):1313–23. https://doi.org/10.1016/j.biopsych.2004.11.024 PMID: 15950004.
9. Franke B, Faraone SV, Asherson P, Buitelaar J, Bau CH, Ramos-Quiroga JA, et al. The genetics of attention deficit/hyperactivity disorder in adults, a review. Molecular psychiatry. 2012; 17(10):960–87. https://doi.org/10.1038/mp.2011.138 PMID: 22105624; PubMed Central PMCID: PMC3449233.
10. Nigg JT, Lewis K, Edinger T, Falk M. Meta-analysis of attention-deficit/hyperactivity disorder or attention-deficit/hyperactivity disorder symptoms, restriction diet, and synthetic food color additives. Journal of the American Academy of Child and Adolescent Psychiatry. 2012; 51(1):86–97 e8. https://doi.org/10.1016/j.jaac.2011.10.015 PMID: 22176942; PubMed Central PMCID: PMC4321798.
11. Sonuga-Barke EJ, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M, et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. The American journal of psychiatry. 2013; 170(3):275–89. https://doi.org/10.1176/appi.ajp.2012.12070991 PMID: 23360949.
12. Pelsser LM, Frankena K, Toorman J, Savelkoul HF, Dubois AE, Pereira RR, et al. Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): a randomised controlled trial. Lancet. 2011; 377(9764):494–503. https://doi.org/10.1016/S0140-6736(10)62227-1 PMID: 21296237.
13. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014; 505(7484):559–63. Epub 2013/12/18. https://doi.org/10.1038/nature12820 PMID: 24336217; PubMed Central PMCID: PMC3957428.
14. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature reviews Neuroscience. 2012; 13(10):701–12. Epub 2012/09/13. https://doi.org/10.1038/nrn3346 PMID: 22968153.
15. Lyte M. Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior. PLoS pathogens. 2013; 9(11):e1003726. https://doi.org/10.1371/journal.ppat.1003726 PMID: 24244158; PubMed Central PMCID: PMC3828163.
16. Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG. The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. Journal of psychiatric research. 2008; 43 (2):164–74. https://doi.org/10.1016/j.jpsychires.2008.03.009 PMID: 18456279.
17. Clayton TA. Metabolic differences underlying two distinct rat urinary phenotypes, a suggested role for gut microbial metabolism of phenylalanine and a possible connection to autism. FEBS letters. 2012; 586(7):956–61. https://doi.org/10.1016/j.febslet.2012.01.049 PMID: 22306194.
18. Gertsman I, Gangoiti JA, Nyhan WL, Barshop BA. Perturbations of tyrosine metabolism promote the indolepyruvate pathway via tryptophan in host and microbiome. Molecular genetics and metabolism. 2015; 114(3):431–7. https://doi.org/10.1016/j.ymgme.2015.01.005 PMID: 25680927.
19. Partty A, Kalliomaki M, Wacklin P, Salminen S, Isolauri E. A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. Pediatric research. 2015; 77(6):823–8. https://doi.org/10.1038/pr.2015.51 PMID: 25760553.
20. Kandel ER, Schwartz JH, Jessell TM. Principles of neural science: McGraw-Hill companies 2000.
21. Institute of Medicine’s Food and Nutrition Board. Dietary Reference Intakes: The Essential Guide to Nutrient Requirements. Available from: http://fnic.nal.usda.gov/dietary-guidance/dietary-referenceintakes/dri-reports.
22. von Rhein D, Mennes M, van Ewijk H, Groenman AP, Zwiers MP, Oosterlaan J, et al. The NeuroIMAGE study: a prospective phenotypic, cognitive, genetic and MRI study in children with attention-deficit/ hyperactivity disorder. Design and descriptives. European child & adolescent psychiatry. 2015; 24 (3):265–81. https://doi.org/10.1007/s00787-014-0573-4 PMID: 25012461.
23. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry. 1997; 36(7):980–8. https://doi.org/10.1097/00004583-199707000-00021 PMID: 9204677.
24. Franke B, Vasquez AA, Veltman JA, Brunner HG, Rijpkema M, Fernandez G. Genetic variation in CAC-NA1C, a gene associated with bipolar disorder, influences brainstem rather than gray matter volume in healthy individuals. Biological psychiatry. 2010; 68(6):586–8. https://doi.org/10.1016/j.biopsych.2010.05.037 PMID: 20638048.
25. Aarts E, Wallace DL, Dang LC, Jagust WJ, Cools R, D’Esposito M. Dopamine and the cognitive downside of a promised bonus. Psychological science. 2014; 25(4):1003–9. Epub 2014/02/15. https://doi.org/10.1177/0956797613517240 PMID: 24525265; PubMed Central PMCID: PMC4163051.
26. Steegenga WT, Mischke M, Lute C, Boekschoten MV, Pruis MG, Lendvai A, et al. Sexually dimorphic characteristics of the small intestine and colon of prepubescent C57BL/6 mice. Biology of sex differences. 2014; 5:11. https://doi.org/10.1186/s13293-014-0011-9 PMID: 25243059; PubMed Central PMCID: PMC4169057.
27. Jaeggi T, Kortman GA, Moretti D, Chassard C, Holding P, Dostal A, et al. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut. 2015; 64(5):731–42. https://doi.org/10.1136/gutjnl-2014-307720 PMID: 25143342.
28. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nature methods. 2010; 7(5):335–6. https://doi.org/10.1038/nmeth.f.303 PMID: 20383131; PubMed Central PMCID: PMC3156573.
29. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic acids research. 2000; 28(1):27–30. PMID: 10592173; PubMed Central PMCID: PMC102409.
30. Pakseresht N, Alako B, Amid C, Cerdeno-Tarraga A, Cleland I, Gibson R, et al. Assembly information services in the European Nucleotide Archive. Nucleic acids research. 2014; 42(Database issue):D38–43. https://doi.org/10.1093/nar/gkt1082 PMID: 24214989; PubMed Central PMCID: PMC3965037.
31. Ottman N, Smidt H, de Vos WM, Belzer C. The function of our microbiota: who is out there and what do they do? Frontiers in cellular and infection microbiology. 2012; 2:104. https://doi.org/10.3389/fcimb.2012.00104 PMID: 22919693; PubMed Central PMCID: PMC3417542.
32. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome research. 2003; 13 (11):2498–504. https://doi.org/10.1101/gr.1239303 PMID: 14597658; PubMed Central PMCID: PMC403769.
33. Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nature biotechnology. 2013; 31(9):814–21. https://doi.org/10.1038/nbt.2676 PMID: 23975157; PubMed Central PMCID: PMC3819121.
34. Vuong HE, Hsiao EY. Emerging Roles for the Gut Microbiome in Autism Spectrum Disorder. Biological psychiatry. 2017; 81(5):411–23. https://doi.org/10.1016/j.biopsych.2016.08.024 PMID: 27773355; PubMed Central PMCID: PMC5285286.
35. Biederman J, Spencer T. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biological psychiatry. 1999; 46(9):1234–42. PMID: 10560028.
36. Staller JA, Faraone SV. Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder. Expert review of neurotherapeutics. 2007; 7(4):351–62. https://doi.org/10.1586/14737175.7.4.351 PMID: 17425490.
37. Gizer IR, Ficks C, Waldman ID. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet. 2009; 126(1):51–90. https://doi.org/10.1007/s00439-009-0694-x PMID: 19506906.
38. Aarts E, van Holstein M, Hoogman M, Onnink M, Kan C, Franke B, et al. Reward modulation of cognitive function in adult attention-deficit/hyperactivity disorder: a pilot study on the role of striatal dopamine. Behavioural pharmacology. 2015; 26(1 and 2):227–40. Epub 2014/12/09. https://doi.org/10.1097/FBP. 0000000000000116 PMID: 25485641.
39. Antshel KM, Waisbren SE. Developmental timing of exposure to elevated levels of phenylalanine is associated with ADHD symptom expression. Journal of abnormal child psychology. 2003; 31(6):565–74. PMID: 14658738.
40. Baker GB, Bornstein RA, Rouget AC, Ashton SE, van Muyden JC, Coutts RT. Phenylethylaminergic mechanisms in attention-deficit disorder. Biological psychiatry. 1991; 29(1):15–22. PMID: 2001444.
41. Bornstein RA, Baker GB, Carroll A, King G, Wong JT, Douglass AB. Plasma amino acids in attention deficit disorder. Psychiatry research. 1990; 33(3):301–6. PMID: 2243904.
42. Bergwerff CE, Luman M, Blom HJ, Oosterlaan J. No Tryptophan, Tyrosine and Phenylalanine Abnormalities in Children with Attention-Deficit/Hyperactivity Disorder. PloS one. 2016; 11(3):e0151100. https://doi.org/10.1371/journal.pone.0151100 PMID: 26938936; PubMed Central PMCID: PMC4777504.
43. Stevenson M, McNaughton N. A comparison of phenylketonuria with attention deficit hyperactivity disorder: do markedly different aetiologies deliver common phenotypes? Brain research bulletin. 2013; 99:63–83. https://doi.org/10.1016/j.brainresbull.2013.10.003 PMID: 24140048.
44. Broadley KJ. The vascular effects of trace amines and amphetamines. Pharmacology & therapeutics. 2010; 125(3):363–75. https://doi.org/10.1016/j.pharmthera.2009.11.005 PMID: 19948186.
45. Fernstrom JD. Large neutral amino acids: dietary effects on brain neurochemistry and function. Amino acids. 2013; 45(3):419–30. https://doi.org/10.1007/s00726-012-1330-y PMID: 22677921.
46. Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. The American journal of psychiatry. 2000; 157(5):816–8. https://doi.org/10.1176/appi.ajp.157.5.816 PMID: 10784477.
47. Arboleya S, Watkins C, Stanton C, Ross RP. Gut Bifidobacteria Populations in Human Health and Aging. Frontiers in microbiology. 2016; 7:1204. https://doi.org/10.3389/fmicb.2016.01204 PMID: 27594848; PubMed Central PMCID: PMC4990546.
48. Yang C, Fujita Y, Ren Q, Ma M, Dong C, Hashimoto K. Bifidobacterium in the gut microbiota confer resilience to chronic social defeat stress in mice. Scientific reports. 2017; 7:45942. https://doi.org/10.1038/srep45942 PMID: 28368029; PubMed Central PMCID: PMC5377462.